DeepDrug™ Team

The LSU DeepDrug team is composed of researchers using artificial intelligence to discover new drugs. Initially focused on finding new antibiotics and antimicrobials, the global COVID-19 pandemic challenged the DeepDrug team to identify new antivirals effective against coronavirus. The DeepDrug technology is a revolutionary way of using AI to discover new drugs as well as identify existing drugs that could be used for other purposes, greatly reducing the time from lab to market. Using AI, the team’s shared goal is to treat illness in ways never before imagined.

DeepDrug™ News

February 22, 2022

New COVID-19 Treatment Developed by Skymount Medical in Partnership with LSU: Skymount Medical, a drug discovery company using an AI platform developed by LSU researchers to repurpose and build new drugs, announced today that it has received approval from the United Kingdom’s MHRA to conduct a human clinical trial of its new oral therapeutic for COVID-19 patients.

November 2, 2021

U.S. Clinical Trials Begin for COVID-19 Oral Therapeutics Discovered Using LSU-Developed Artificial Intelligence: First patient study in North America to investigate a new combination of two previously FDA-approved drugs identified as effective against COVID-19 by DeepDrug, an artificial intelligence platform developed by Louisiana State University (LSU) researchers.

August 10, 2021

Human Studies Start for Promising COVID-19 Treatment Discovered by LSU DeepDrug Team Using Artificial Intelligence: New combination of already FDA-approved compounds can prevent extreme and lasting symptoms, cut hospitalizations.

The mapping we do between viral activity, antiviral peptides, and known drug compounds in one unifying framework is a critical component. It’s challenging but exciting work.

Michal BrylinskiLSU Rainmaker and associate professor in the Department of Biological Sciences with a joint appointment in the Center for Computation & Technology

Meet the Team

Computer scientist and LSU Professor Supratik Mukhopadhyay leads the team that developed the DeepDrug™ Artificial Intelligence Platform.

Q&A with Dr. Mukhopadhyay

This website uses cookies to ensure site visitors get the best experience on our website. By continuing to use this site, you accept our use of cookies and Privacy Statement. To learn more, please visit LSU Privacy Statement.